GSK Investigational Site

Frankenthal, Rhineland-Palatinate 67227

0 studies enrolling now · 1 studies all time

What they study most

Infections, Rotavirus, Rotavirus Vaccines

Studies at this site

• Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks — Completed